Format

Send to

Choose Destination
Rev Med Suisse. 2011 Jan 12;7(277):75-6, 78-9.

[Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].

[Article in French]

Author information

1
Service de rhumatologie, D├ępartement de l'appareil locomoteur, CHUV, 1011 Lausanne. melanie.faucherre@chuv.ch

Abstract

Anti-TNF alpha are immunomodulatory treatments prescribed for some rheumatologic inflammatory diseases (ex: spondylarthropathy, rheumatoid polyarthritis). The randomised studies suggested that anti-TNF alpha therapy is associated with an overall risk of infectious diseases. The results of the observational studies are more reassuring. In this article, we will describe some results of theses studies and propose some practical recommendations in use of the anti-TNF alpha therapy.

PMID:
21309182
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center